explore -WSS

explore

author：explore 2025-09-30 16:25:53 - browse：733

Garry Tan, CEO of Y Combinator Seb Daly/Web Summi

WASHINGTON — In San Francisco, Y Combinator’s firebrand chief executive Garry Tan is one of the startup economy’s most recognizable figures. Well before he became the leader of the coveted startup accelerator that bred global brands like Airbnb, Stripe and OpenAI, Tan was a self-made founder who sold his own company to Twitter.

But here in the nation’s political capital, Tan is far less known. He’s hoping to grow his influence here, offering up his vast network of founders as a source of expertise for regulators struggling to wrap their heads around new technologies like artificial intelligence and how best to rein it in.

“We’re happy to be a phone-a-friend for people who are trying to understand tech,” he told the Economic Club of Washington recently when asked how he’d measure success during Y Combinator’s first-ever policy-focused visit. “‘Little tech’ represents competition, and consumer choice,” he said later at a separate event in a dimly lit Senate room filled with a few dozen Congressional staffers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： STAT Readout Newsletter: Biotech news today

WSS

The problems with dementia villages

How AI can help patients find reliable information about doctors

FDA seeking to stop procedures at two unregulated stem cell clinics

Smaller biotechs seek to piggyback on weight loss drug boom

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Lack of darker skin in textbooks, journals harms patients of color

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

ChatGPT in medicine: STAT answers readers' burning questions

FDA clears Verve to begin U.S. study of gene

In age of alternative facts, a scholarly course on calling out crap

House passes resolution saying Israel isn't a 'racist or apartheid state'

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout LOUD podcast: Live from the 2023 STAT Summit

Continuity nursing helped my family in our darkest PICU moments

FDA seeking to stop procedures at two unregulated stem cell clinics

Novavax promises a turnaround & Lilly roils the obesity market

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

knowledge

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Manchin plays down potential 3rd

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

STAT Summit: Meghan O’Rourke on making chronic illness visible

STAT Summit: Meghan O’Rourke on making chronic illness visible

Manchin plays down potential 3rd

knowledge

leisure time

entertainment

hotspot